The Cooper Companies, Inc. logo

The Cooper Companies, Inc. (CP60)

Market Closed
8 Jan, 20:00
XFRA XFRA
89. 30
+0.45
+0.51%
- Market Cap
- P/E Ratio
0.12% Div Yield
400 Volume
- Eps
88.85
Previous Close
Day Range
89.15 89.3
Year Range
78.55 101
Earnings results expected in 42 days

Summary

CP60 closed Wednesday higher at €89.3, an increase of 0.51% from Tuesday's close, completing a monthly increase of 0.79% or €0.7. Over the past 12 months, CP60 stock gained 0.79%.
CP60 pays dividends to its shareholders, with the most recent payment made on Aug 11, 2023. The next estimated payment will be in 11 months ago on Feb 11, 2024 for a total of €0.0075.
The last earnings report, released on Dec 05, 2024, exceeded the consensus estimates by 0.04%. On average, the company has surpassed earnings expectations by 0.04%, based on the last three reports. The next scheduled earnings report is due on Feb 26, 2025.
The Cooper Companies, Inc. has completed 0 stock splits, with the recent split occurring on Feb 20, 2024.
The company's stock is traded on 6 different exchanges and in various currencies, with the primary listing on XFRA (EUR).
Want to track CP60 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

CP60 Chart

FAQ

What Is the The Cooper Companies, Inc.(CP60) Stock Price Today?

The CP60 stock price today is €89.30.

What Stock Exchange Does The Cooper Companies, Inc. Trade On?

The Cooper Companies, Inc. is listed and trades on the NASDAQ (NGS).

What Is the Stock Symbol for The Cooper Companies, Inc.?

The stock symbol for The Cooper Companies, Inc. is "CP60".

Does The Cooper Companies, Inc. Pay Dividends? What's The Current Dividend Yield?

CP60 is not paying dividends to its shareholders.

What Is the The Cooper Companies, Inc. Market Cap?

As of today, The Cooper Companies, Inc. does not have a market cap available.

What is The Cooper Companies, Inc. Earnings Per Share?

The The Cooper Companies, Inc. EPS is 0.

What Is the Next The Cooper Companies, Inc. Earnings Date?

The Cooper Companies, Inc. will release its next earnings report on Feb 26, 2025.

Did The Cooper Companies, Inc. had any splits?

The Cooper Companies, Inc. had 0 splits and the recent split was on Feb 20, 2024.

The Cooper Companies, Inc. Profile

Medical Instruments & Supplies Industry
Healthcare Sector
Mr. Albert G. White III CEO
XFRA Exchange
US2166484020 ISIN
United States Country
15,000 Employees
26 Jul 2023 Last Dividend
20 Feb 2024 Last Split
- IPO Date

Overview

The Cooper Companies, Inc., established in 1958 and headquartered in San Ramon, California, is a global entity that specializes in the development, manufacture, and marketing of contact lenses through its subsidiaries. The operations of the company are segmented into CooperVision and CooperSurgical. CooperVision focuses on providing a variety of contact lenses including those for correcting nearsightedness, farsightedness, astigmatism, presbyopia, and myopia across various regions such as the Americas, Europe, Middle East, Africa, and Asia Pacific. On the other hand, CooperSurgical addresses family and women's health, offering a wide range of fertility products and services, medical devices, contraception, and cryostorage services for cord blood and tissue to healthcare professionals and patients globally. The products offered by The Cooper Companies, Inc. reach their end-users through distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals, clinics, and authorized resellers.

Products and Services

CooperVision:

  • Spherical Lenses: These lenses are designed to correct common vision problems such as nearsightedness and farsightedness.
  • Toric and Multifocal Lenses: These lenses provide solutions for more complex vision challenges, including astigmatism, presbyopia, and myopia, catering to a diverse range of contact lens wearers.

CooperSurgical:

  • Fertility Products and Services: Includes consumables, equipment, donor gamete services, and genomic services such as genetic testing, designed to support the varying needs of fertility treatments.
  • Medical Devices and Contraception: Ranging from Paragard contraceptive IUDs, endosee endometrial imaging, and Mara water ablation systems, these products aim to provide innovative solutions in women's healthcare and family planning.
  • Cryostorage Services: Offering storage solutions for cord blood and tissue, these services play a crucial role in regenerative medicine and future health considerations.
  • Surgical and Office Products: This encompasses a broad spectrum of devices and tools such as illuminated speculum products, lone star retractor systems, and fetal pillow cephalic elevation devices, used across gynecological procedures and office-based diagnostics.

Contact Information

Address: 6101 Bollinger Canyon Road
Phone: 925 460 3600